![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ANTXR2 |
Gene summary for ANTXR2 |
![]() |
Gene information | Species | Human | Gene symbol | ANTXR2 | Gene ID | 118429 |
Gene name | ANTXR cell adhesion molecule 2 | |
Gene Alias | CMG-2 | |
Cytomap | 4q21.21 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | P58335 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
118429 | ANTXR2 | ATC1 | Human | Thyroid | ATC | 2.63e-07 | 3.43e-01 | 0.2878 |
118429 | ANTXR2 | ATC2 | Human | Thyroid | ATC | 2.02e-16 | 9.89e-01 | 0.34 |
118429 | ANTXR2 | ATC3 | Human | Thyroid | ATC | 9.90e-24 | 1.08e+00 | 0.338 |
118429 | ANTXR2 | ATC4 | Human | Thyroid | ATC | 2.23e-32 | 6.73e-01 | 0.34 |
118429 | ANTXR2 | ATC5 | Human | Thyroid | ATC | 2.91e-14 | 2.67e-01 | 0.34 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:19019986 | Oral cavity | OSCC | toxin transport | 25/7305 | 40/18723 | 2.22e-03 | 1.00e-02 | 25 |
GO:19019985 | Prostate | BPH | toxin transport | 15/3107 | 40/18723 | 1.21e-03 | 7.41e-03 | 15 |
GO:190199811 | Prostate | Tumor | toxin transport | 16/3246 | 40/18723 | 5.99e-04 | 4.29e-03 | 16 |
GO:190199813 | Thyroid | ATC | toxin transport | 25/6293 | 40/18723 | 1.72e-04 | 1.17e-03 | 25 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa046218 | Oral cavity | OSCC | NOD-like receptor signaling pathway | 108/3704 | 186/8465 | 5.13e-05 | 2.07e-04 | 1.05e-04 | 108 |
hsa0462113 | Oral cavity | OSCC | NOD-like receptor signaling pathway | 108/3704 | 186/8465 | 5.13e-05 | 2.07e-04 | 1.05e-04 | 108 |
hsa046214 | Oral cavity | EOLP | NOD-like receptor signaling pathway | 48/1218 | 186/8465 | 2.51e-05 | 1.31e-04 | 7.70e-05 | 48 |
hsa046215 | Oral cavity | EOLP | NOD-like receptor signaling pathway | 48/1218 | 186/8465 | 2.51e-05 | 1.31e-04 | 7.70e-05 | 48 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ANTXR2 | SNV | Missense_Mutation | c.1160N>T | p.Gly387Val | p.G387V | P58335 | protein_coding | deleterious(0) | probably_damaging(0.952) | TCGA-D8-A1J9-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ANTXR2 | SNV | Missense_Mutation | c.1130N>T | p.Asp377Val | p.D377V | P58335 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-A6-5661-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ANTXR2 | SNV | Missense_Mutation | novel | c.217N>A | p.Phe73Ile | p.F73I | P58335 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ANTXR2 | SNV | Missense_Mutation | c.390N>C | p.Gln130His | p.Q130H | P58335 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
ANTXR2 | SNV | Missense_Mutation | rs767242762 | c.1295N>A | p.Arg432Gln | p.R432Q | P58335 | protein_coding | tolerated(0.11) | benign(0.029) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
ANTXR2 | SNV | Missense_Mutation | c.1123N>C | p.Thr375Pro | p.T375P | P58335 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-AA-A01P-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
ANTXR2 | SNV | Missense_Mutation | c.1172N>T | p.Arg391Ile | p.R391I | P58335 | protein_coding | deleterious(0) | probably_damaging(0.981) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
ANTXR2 | SNV | Missense_Mutation | c.293N>G | p.Asp98Gly | p.D98G | P58335 | protein_coding | deleterious(0) | possibly_damaging(0.765) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
ANTXR2 | SNV | Missense_Mutation | rs756324499 | c.958N>A | p.Ala320Thr | p.A320T | P58335 | protein_coding | tolerated(0.41) | possibly_damaging(0.677) | TCGA-D5-6928-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ANTXR2 | SNV | Missense_Mutation | c.1034G>T | p.Cys345Phe | p.C345F | P58335 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-AH-6544-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |